NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-131-2020-7-TW-08 Anti-Coronavirus Antibodies And Methods Of Use TW ORD 109144053 Issued
NIAID E-131-2020-7-HK-13 Anti-Coronavirus Antibodies And Methods Of Use HK EP 42021039063.9 Pending
NIAID E-131-2020-7-GB-12 Anti-Coronavirus Antibodies And Methods Of Use GB ORD 2019709.1 Pending
NIAID E-131-2020-7-AR-03 Anti-Coronavirus Antibodies And Methods Of Use AR ORD 20200103485 Pending
NIAID E-131-2020-7-EP-10 Anti-Coronavirus Antibodies And Methods Of Use EP ORD 20213900.2 Pending
NIAID E-131-2020-7-GC-04 Anti-Coronavirus Antibodies And Methods Of Use GC ORD 41303 Pending
NIAID E-131-2020-7-LB-06 Anti-Coronavirus Antibodies And Methods Of Use LB ORD 12076 Pending
NIAID E-131-2020-7-PK-01 Anti-Coronavirus Antibodies And Methods Of Use PK ORD 855/2020 Pending
NIAID E-153-2019-1-JP-09 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE JP National Stage 2022-535470 Issued
NIAID E-018-2018-0-CN-07 CHIMERIC VECTORS CN National Stage 201980039372.6 Issued
NIAID E-153-2019-1-PCT-01 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE PCT PCT COMB PCT/US2020/064619 Expired
NCI E-003-2020-0-PCT-02 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY PCT PCT PCT/US2020/064412 Expired
NIAID E-153-2019-1-CN-05 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE CN National Stage 202080096383.0 Pending
NCI E-003-2020-0-CN-04 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY CN National Stage 202080086575.3 Pending
NIAID E-153-2019-1-EP-06 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE EP National Stage 20841798.0 Pending
NCI E-003-2020-0-EP-05 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY EP National Stage 20899103.4 Pending
NCI E-147-2021-0-US-01 COMPOSITIONS AND METHODS FOR TREATING CANCER US 63/124,231 Abandoned
NIAID E-153-2019-1-CA-04 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE CA National Stage 3164343 Pending
NCI E-003-2020-0-AU-03 PERSONALIZED TUMOR VACCINE AND USE THEREOF FOR CANCER IMMUNOTHERAPY AU National Stage 2020403013 Pending
NIAID E-153-2019-1-BR-03 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE BR National Stage BR112022011422-2 Pending
NIAID E-153-2019-1-AU-02 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE AU National Stage 2020402106 Pending
NIAID E-153-2019-1-ZA-14 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE ZA National Stage 2022/06497 Pending
NIAID E-153-2019-1-SG-12 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE SG National Stage 11202250095U Pending
NIAID E-153-2019-1-IN-08 MUMPS AND MEASLES VIRUS IMMUNOGENS AND THEIR USE IN National Stage 202217038319 Pending
NICHD E-026-2019-0-US-03 POLYPEPTIDES, NUCLEIC ACID MOLECULES, COMPOSITIONS, AND RELATED METHODS US National Stage 17/251,019 12054526 Issued PDF
NCI E-040-2012-0-US-60 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/117,335 11377660 Issued PDF
NCI E-040-2012-0-US-61 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/117,368 11359204 Issued PDF
NCI E-040-2012-0-US-59 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen US CON 17/117,311 11066674 Issued PDF
NCATS E-114-2018-0-EP-05 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS EP National Stage 19728226.2 Issued
NCATS E-114-2018-0-GB-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS GB EP 19728226.2 Issued
NCATS E-114-2018-0-DE-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS DE EP 19728226.2 Issued
NCATS E-114-2018-0-TR-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS TR EP 19728226.2 Issued
NCATS E-114-2018-0-ES-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS ES EP 19728226.2 Issued
NCATS E-114-2018-0-IT-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS IT EP 19728226.2 Issued
NCATS E-114-2018-0-FR-01 FORMULATIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS FR EP 19728226.2 Issued
NIAID E-131-2020-7-PCT-01 Anti-Coronavirus Antibodies And Methods Of Use PCT PCT COMB PCT/US2020/063991 Expired
NIAID E-131-2020-7-CN-01 Anti-Coronavirus Antibodies And Methods Of Use CN National Stage 202080100619.3 Pending
NIAID E-131-2020-7-CA-16 Anti-Coronavirus Antibodies And Methods Of Use CA National Stage 3171237 Pending
NIAID E-131-2020-7-EG-17 Anti-Coronavirus Antibodies And Methods Of Use EG National Stage 1290/2022 Pending
NIAID E-131-2020-7-IL-18 Anti-Coronavirus Antibodies And Methods Of Use IL National Stage 296224 Pending
NIAID E-131-2020-7-BR-15 Anti-Coronavirus Antibodies And Methods Of Use BR National Stage BR112022017986-3 Pending
NIAID E-131-2020-7-AU-14 Anti-Coronavirus Antibodies And Methods Of Use AU National Stage 2020435452 Abandoned
NIAID E-131-2020-7-ZA-19 Anti-Coronavirus Antibodies And Methods Of Use ZA National Stage 2022/10039 Pending
NIAID E-131-2020-7-MX-20 Anti-Coronavirus Antibodies And Methods Of Use MX National Stage MX/a/2022/011142 Pending
NINDS E-198-2021-0-GB-01 UNC13A Disease Polymorphisms Lead To Increased Cryptic Exon Expression In Settings Of TDP-43 Deficiency GB 2019418.9 Expired
NIAID E-198-2025-0-US-11 VIRAL SEROLOGY ASSAYS US 63/123,108 Expired
NIAID E-131-2020-7-US-02 Anti-Coronavirus Antibodies And Methods Of Use US ORD 17/116,588 Abandoned
NCI E-145-2019-0-JP-06 ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD276 AND USES THEREOF JP National Stage 2022-535127 Issued
NIAID E-145-2011-0-US-17 PLASMODIAL SURFACE ANION CHANNEL INHIBITORS FOR THE TREATMENT OR PREVENTION OF MALARIA US DIV 17/115,317 12059418 Issued PDF
NIAID E-145-2015-3-US-15 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US CON 17/115,026 11571409 Issued PDF